Relationship Between Age, Gender, and Comorbids with the Profile of Gallstone Types in Cholecystectomy Patients
Main Article Content
Abstract
Cholelithiasis, the formation of gallstones in the gallbladder or its ducts, is generally asymptomatic and is only detected incidentally through imaging (60–80% of cases are asymptomatic). Serious complications such as biliary colic, acute cholecystitis, cholangitis, and pancreatitis have been reported in some patients when stones obstruct bile flow. Several studies have shown that age, gender, and the presence of comorbidities such as obesity and diabetes mellitus play a significant role in the development of certain types of gallstones. Objective: To determine the relationship between age, gender, and comorbidities with the profile of gallstone types in cholecystectomy patients at Haji General Hospital, Surabaya, in 2023–2024. Method: This study used a retrospective descriptive approach with a cross-sectional study design. The population in this study consisted of patients at Haji General Hospital, Surabaya, who were diagnosed with cholelithiasis and undergoing cholecystectomy therapy. The sample inclusion criteria included patients with a profile of gallstone types documented in the medical records of the Clinical Pathology Laboratory at Haji General Hospital, Surabaya, following cholecystectomy procedures. The sampling method in this study used the total sampling method. Results: The majority were female, comprising 51 people (65.4%). The most significant number of respondents was in the 40–59 years age group, with 36 people (46.2%). Most respondents suffered from mixed types of stones, namely 67 people (85.9%). Respondents did not have comorbidities in 52.6% of cases; the rest had comorbidities in various forms, including others (26.9%), hypertension (10.3%), and diabetes mellitus (10.3%). Conclusion: There was no significant relationship between age, gender, and comorbidities with the type of gallstones in cholecystectomy patients (p > 0.05).
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Beckingham IJ. ABC of diseases of liver, pancreas, and biliary system: Gallstone disease. Br Med J. 2001;322(7278):91-94. doi:10.1136/bmj.322.7278.91
II. Ciaula Di, A., Wang, D. Q. H., Portincasa, P. (2022). An update on the pathogenesis of cholesterol gallstones. Current Opinion in Gastroenterology, 38(2), 123–131.
III. European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the prevention, diagnosis and treatment of gallstones. J Hepatol 2016;65:146-81.
IV. Gu Q, Zhou G, Xu T. Risk factors for gallstone disease in Shanghai: An observational study. Medicine (Baltimore). 2020 ; 99: e18754.
V. Jones MW, Weir CB, Marietta M. Gallstones (Cholelithiasis). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025
VI. Lammert, F.; Gurusamy, K.; Ko, CW; Miquel, J.-F.; Méndez-Sánchez, N.; Portincasa, P.; van Erpecum, KJ; van Laarhoven, CS; Wang, DQ-H. Gallstones. Nature Reviews Disease Primers.. 2016; vol 2: 16024
VII. Morimoto M, Takahiro Matsuo, Nobuyoshi Mori. Management of Porcelain Gallbladder, Its Risk Factors, and Complications: A Review. Diagnostics 2021, 11(6),
; https://doi.org/10.3390/diagnostics11061073
VIII. Shaffer EA. Gallstone disease: Epidemiology of gallstone disease. Best Pract Res Clin Gastroenterol 2006;20:981-96.
IX. Song ST, Shi J, Wang XH, et al. Prevalence and risk factors of gallstone disease: A population-based cross-sectional study. J Dig Dis 2020;21:237-45.
X. Stinton LM, Myers RP, Shaffer EA. Epidemiology of gallstones. Gastroenterol Clin North Am 2010;39:157-69, vii.
XI. Tanaja J, Lopez RA, Meer JM. Cholelithiasis (Archived) [Updated 2024 Aug 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025
XII. Utami, R. A., et al. (2021). Profil pasien kolelitiasis yang menjalani kolesistektomi di RSUP Dr. Sardjito Yogyakarta. Jurnal Kedokteran, 11(2), 95–101
XIII. Yang Song, et al. Age, gender, geographic and clinical differences for gallstones in China: a nationwide study. Ann Transl Med. 2022 Jul;10(13):735
XIV. Zhao, Y., Yang, Y., et al. (2019). Pathogenesis and treatment of cholesterol gallstones: Role of metabolic syndrome. Frontiers in Medicine, 6, 278.
XV. Zhu L, Aili A, Zhang C, et al. Prevalence and risk factors of gallstones in Uighur and Han ethnic groups. World J Gastroenterol 2014 ; 20 : 14942-9.